ESMO
-
ESMO’22 Recommended Abstracts in RENAL CANCERS
Robert A. Figlin, MD, Editor-in- Chief of the Kidney Cancer Journal. These recommended abstracts from ESMO 2022 Annual meeting have been…
Read More » -
A 20-year retrospective: How Kidney Cancer Journal Reflected on Advances in The Therapeutic Strategies
Robert A Figlin, MD, FACP1 , Senthil Pazhanisamy, PhD2 1. Cedars-Sinai Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Health System, Los Angeles…
Read More » -
2022 ESMO: Promise and Pitfalls of Adjuvant Immunotherapy
ESMO’22 Special Robert A. Figlin, MD, FACS Cedars Cinai Cancer Center, Los Angeles, CA Correspondence: RAF There was never a…
Read More »
